Product image of Melodyn Long (Buprenorphine) supplied by GNH India

Melodyn Long

Active Ingredient:
Buprenorphine
Origin:
EU

Melodyn Long (Buprenorphine)

Buprenorphine, the active ingredient in Melodyn Long, is an opioid analgesic presented as a transdermal patch for transdermal use. It provides analgesia for moderate to severe chronic pain in adult patients requiring continuous opioid therapy.

GNH India supplies Melodyn Long as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved products across multiple markets. Its distribution network ensures reliable delivery, temperature‑controlled packaging where required, and comprehensive documentation for import compliance.

Manufacturer / TM Owner

G.L. Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Buprenorphine is used in the management of chronic pain conditions requiring opioid therapy.

  • Chronic non‑cancer pain: provides continuous analgesia for patients with persistent moderate to severe pain.
  • Cancer‑related pain: offers stable opioid delivery for breakthrough pain control.
  • Post‑surgical pain (when oral opioids not feasible): maintains analgesia during recovery.

How It Works

  • Buprenorphine binds as a partial agonist to the µ‑opioid receptor and as an antagonist to the κ‑opioid receptor, producing analgesia while limiting maximal respiratory depression. Delivered through a transdermal matrix, the patch allows steady systemic absorption, maintaining plasma concentrations that provide sustained pain relief with a ceiling effect on respiratory compromise.

Side Effects

Buprenorphine transdermal therapy may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Application site erythema: redness at the patch site.
  • Pruritus: itching around the patch area.
  • Nausea: mild to moderate feeling of sickness.
  • Constipation: reduced bowel movements.

Serious or Rare Side Effects

  • Respiratory depression: reduced breathing, especially with other depressants.
  • Hypotension: low blood pressure episodes.
  • Seizures: rare occurrence of convulsive events.

Precautions & Warnings

Before initiating therapy, clinicians should consider several safety measures.

  • Assess respiratory function: evaluate baseline breathing before starting treatment.
  • Avoid concomitant CNS depressants: limit use of benzodiazepines, alcohol, and other sedatives.
  • Monitor for signs of opioid dependence: watch for withdrawal symptoms during dose changes.
  • Adjust dose in hepatic impairment: consider reduced exposure in patients with liver dysfunction.
  • Educate patient on patch disposal: fold used patch and keep out of reach of children.
  • Store at room temperature: keep below 25°C, protect from moisture and direct sunlight.

Avoid Interactions

Buprenorphine may interact with other medicines, requiring careful management.

Major Interactions (Avoid)

  • Benzodiazepines: additive central nervous system depression.
  • Other opioids: risk of overdose and respiratory depression.
  • CYP3A4 inhibitors (e.g., ketoconazole): increased buprenorphine plasma levels.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inducers (e.g., rifampin): reduced efficacy of the patch.
  • Alcohol: enhanced sedation and respiratory effects.
  • Anticholinergics: may worsen constipation associated with opioid therapy.

Frequently Asked Questions

Melodyn Long is a transdermal buprenorphine patch indicated for the management of moderate to severe chronic pain, including both non‑cancer and cancer‑related pain, when continuous opioid therapy is required.

Buprenorphine acts as a partial agonist at the µ‑opioid receptor and an antagonist at the κ‑opioid receptor. This dual activity provides analgesia while limiting the ceiling effect on respiratory depression, resulting in steady pain control when delivered through a patch.

The prescribed dose of Melodyn Long is determined by the treating clinician based on the patient’s pain severity, prior opioid exposure, and clinical response. Different patch strengths are available, and the prescriber selects the appropriate strength and replacement interval.

Data on buprenorphine use during pregnancy and lactation are limited. Because potential risks to the fetus or infant cannot be ruled out, the patch should generally be avoided unless the benefit clearly outweighs the risk and no safer alternative is available.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with full‑agonist opioid patches such as fentanyl, buprenorphine has a partial µ‑opioid agonist profile, offering a lower risk of severe respiratory depression and a ceiling effect on respiratory compromise, while still delivering effective analgesia for chronic pain.

Melodyn Long should be stored at room temperature, below 25 °C, in its original packaging. Keep the patches away from moisture, direct sunlight, and heat sources to maintain product stability and efficacy.

The patch is applied to clean, dry, hair‑free skin on the upper torso or upper arm. Press firmly for at least 30 seconds, then replace the patch according to the prescribed interval, usually every 7 days, ensuring the previous patch is removed and disposed of safely.

The most serious risks include respiratory depression, especially when combined with other CNS depressants, severe hypotension, and rare events such as seizures. Patients should be monitored for signs of breathing difficulty, low blood pressure, or unusual neurological symptoms.

Melodyn Long is contraindicated in patients with known hypersensitivity to buprenorphine or any patch components, those with severe respiratory depression, acute or severe asthma, and individuals using monoamine oxidase inhibitors within 14 days. Caution is also advised in patients with significant hepatic impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Buprenorphine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT